AQR Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$536K Sell
2025
Q1
$646K Buy
2024
Q4
Sell
2024
Q3
$143K Buy
2024
Q2
Sell
2024
Q1
$125K Buy
2023
Q2
Sell
2023
Q1
$172K Sell
2022
Q4
$637K Buy